TCW Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-141,924
| Closed | -$2.93M | – | 373 |
|
|
2023
Q3 | $2.93M | Buy |
141,924
+51,953
| +58% | +$1.07M | 0.04% | 199 |
|
|
2023
Q2 | $2.66M | Buy |
89,971
+1,660
| +2% | +$49K | 0.03% | 218 |
|
|
2023
Q1 | $2.03M | Buy |
88,311
+49,280
| +126% | +$1.14M | 0.03% | 214 |
|
|
2022
Q4 | $1.09M | Buy |
+39,031
| New | +$1.09M | 0.02% | 246 |
|